Medplus Health Services · NSE: MEDPLUS · BSE: 543427

Q4 FY26 results · Jan–Mar 2026

Medplus Health Services reported revenue from operations of ₹1,864.38 crore (up 23.5% from Q4 FY25) and net profit of ₹63.97 crore (up 24.7% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations1,864.381,509.61+23.5%1,806.12+3.2%
Other income20.5915.79+30.4%18.24+12.9%
Total income1,884.981,525.40+23.6%1,824.36+3.3%
Profit before tax80.3461.12+31.5%73.29+9.6%
Net profit for the period63.9751.32+24.7%57.79+10.7%
Attributable to shareholders of the company63.9851.34+24.6%57.81+10.7%
EPS, basic (₹)5.334.32+23.4%4.82+10.6%
Net margin (%)3.43.43.2
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations248.04201.75+22.9%223.00+11.2%
Other income2.492.65−6.2%2.70−7.8%
Total income250.52204.40+22.6%225.70+11.0%
Profit before tax23.0617.91+28.7%21.83+5.6%
Net profit for the period16.6713.98+19.2%16.58+0.6%
EPS, basic (₹)1.391.17+18.8%1.38+0.7%
Net margin (%)6.76.97.4
Consolidated
Filed with BSE
20 May 2026, 22:16 IST
Board meeting
20 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
20 May 2026, 22:16 IST
Board meeting
20 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE